Therefore, this study used the risk of ovarian malignancy algorithm (ROMA) associated with HE4 and CA125 levels as the main indicator to explore the risk of ovarian cancer in middle-aged and elderly women with RA and its correlation with disease activity. The gene discussed is MUC16; the disease is ovarian cancer.